In this article, we will take a look at the 5 best penny stocks to buy under $1. To see more such companies, go directly to 12 Best Penny Stocks to Buy Under $1.
5. Cano Health, Inc. (NYSE:CANO)
Number of Hedge Fund Holders: 21
Cano Health, Inc. (NYSE:CANO) said in September that it sold substantially all the assets related to its senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care for about $66.7 million. In late September Cano Health, Inc. appointed Eladio Gil as its interim CFO.
A total of 21 hedge funds in Insider Monkey’s database had stakes in Cano Health, Inc. as of the end of the second quarter of 2023. The most significant stakeholder of Cano Health, Inc. was
4. Heron Therapeutics, Inc. (NASDAQ:HRTX)
Number of Hedge Fund Holders: 22
Insider Monkey’s proprietary database of 910 hedge funds shows that 22 funds had stakes in Heron Therapeutics, Inc. (NASDAQ:HRTX) The biggest stakeholder of Heron Therapeutics, Inc. was David Rosen’s Rubric Capital Management which had a $14 million stake in the company.
3. FibroGen, Inc. (NASDAQ:FGEN)
Number of Hedge Fund Holders: 22
Yet another biopharma company in our list of the best penny stocks under $1, FibroGen, Inc. (NASDAQ:FGEN) is working on treatments for serious unmet medical needs, including idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy.
A total of 22 hedge funds in Insider Monkey’s database of hedge funds had stakes in FibroGen, Inc.. The biggest stake in FibroGen, Inc. was owned by Steven Boyd’s Armistice Capital which owns a $12 million stake in the company.
2. Qurate Retail, Inc. (NASDAQ:QRTEA)
Number of Hedge Fund Holders: 25
Ecommerce and media company Qurate Retail, Inc. (NASDAQ:QRTEA) is one of the notable penny stocks owned by hedge funds. A total of 25 hedge funds tracked by Insider Monkey had stakes in Qurate Retail, Inc.. The biggest stakeholder of Qurate Retail, Inc. was Bob Peck and Andy Raab’s FPR Partners which owns a $28 million stake in the company.
1. Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Number of Hedge Fund Holders: 26
Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares jumped in August after the company announced data from its CLEAR Outcomes program for the cholesterol-lowering agent bempedoic acid at a European medical event.
Insider Monkey’s database of hedge funds shows 26 hedge funds were long Esperion Therapeutics, Inc.. Steven Boyd’s Armistice Capital had a $13 million stake in Esperion Therapeutics, Inc..
You can also take a peek at 15 Most Innovative Companies in Canada and 15 Best Casino Stocks To Buy Heading Into 2024.
